vTv Therapeutics Inc.

VTVT · Nasdaq · SIC 2834: Pharmaceutical Preparations
244
SEC Filings

Business Summary

PART I Overview We are a late-stage biopharmaceutical company focused on developing orally administered therapies for metabolic and inflammatory diseases with the goal of improving patient outcomes. Our lead product candidate, cadisegliatin (TTP399) , is a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated in a Phase 3 clinical trial as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). The Cadisegliatin as Adjunct...

Next Earnings

Q2 FY2026 — expected 2026-09-07

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVTVTdiscussed_in_filing Artificial Intelligence
topic_mentionVTVTdiscussed_in_filing Cybersecurity
topic_mentionVTVTdiscussed_in_filing Trusted Computing
topic_mentionVTVTdiscussed_in_filing Blockchain & Crypto
topic_mentionVTVTdiscussed_in_filing Autonomous Vehicles
topic_mentionVTVTdiscussed_in_filing Regulation
topic_mentionVTVTdiscussed_in_filing Healthcare & Bio
topic_mentionVTVTdiscussed_in_filing Artificial Intelligence
topic_mentionVTVTdiscussed_in_filing Cybersecurity
topic_mentionVTVTdiscussed_in_filing Trusted Computing
topic_mentionVTVTdiscussed_in_filing Blockchain & Crypto
topic_mentionVTVTdiscussed_in_filing Autonomous Vehicles
topic_mentionVTVTdiscussed_in_filing Regulation
topic_mentionVTVTdiscussed_in_filing Healthcare & Bio
topic_mentionVTVTdiscussed_in_filing Artificial Intelligence
topic_mentionVTVTdiscussed_in_filing Cybersecurity
topic_mentionVTVTdiscussed_in_filing Trusted Computing
topic_mentionVTVTdiscussed_in_filing Blockchain & Crypto
topic_mentionVTVTdiscussed_in_filing Autonomous Vehicles
topic_mentionVTVTdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001641489-26-000010EDGAR68K words
2025-03-202024-12-310001641489-25-000014EDGAR—
2024-03-132023-12-310001641489-24-000012EDGAR—
2023-03-062022-12-310001641489-23-000008EDGAR—
2022-03-292021-12-310001564590-22-012258EDGAR—
2021-02-242020-12-310001564590-21-008149EDGAR—
2020-02-212019-12-310001564590-20-005627EDGAR—
2019-02-262018-12-310001564590-19-004516EDGAR—
2018-02-272017-12-310001564590-18-003515EDGAR—
2017-02-242016-12-310001564590-17-002317EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001641489-25-000060EDGAR17K words
2025-08-122025-06-300001641489-25-000053EDGAR—
2025-05-152025-03-310001641489-25-000026EDGAR—
2024-11-122024-09-300001641489-24-000075EDGAR—
2024-08-082024-06-300001641489-24-000061EDGAR—
2024-05-092024-03-310001641489-24-000029EDGAR—
2023-11-092023-09-300001641489-23-000070EDGAR—
2023-08-112023-06-300001641489-23-000053EDGAR—
2023-05-112023-03-310001641489-23-000021EDGAR—
2022-11-102022-09-300001641489-22-000015EDGAR—
2022-08-152022-06-300001641489-22-000008EDGAR—
2022-05-122022-03-310001564590-22-019652EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-100001641489-26-000012EDGAR3K words
2026-03-100001641489-26-000011EDGAR—
2026-02-260001641489-26-000005EDGAR—
2026-02-020001641489-26-000002EDGAR—
2025-12-190001641489-25-000066EDGAR—
2025-11-060001641489-25-000058EDGAR—
2025-09-100001641489-25-000055EDGAR—
2025-09-020001193125-25-193486EDGAR—
2025-08-120001641489-25-000051EDGAR—
2025-06-120001641489-25-000038EDGAR—

244 total filings indexed. 212 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001641489
TickerVTVT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e3524a641de813db356471e2523f7078d0a55f0122473c184c958de03a535942
parent: 873d2a7dbf564357480903592c0e62744c12b10d0ead5e83ee8468295dae52d0
content hash: 53690654cf09690268181be1398dc9601be990fa822b0ef864ab978cd30a1cb8
signed: 2026-04-13T04:48:09.696Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf